Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 13,662 shares at $30.95 ($424K) on 2016-10-03, disclosed to the SEC on 2016-10-05.
Open-market sale of $424k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.95 | 5,481 | $170K | 40.0% |
| 2 | $30.95 | 5,481 | $170K | 40.0% |
| 3 | $31.55 | 2,700 | $85K | 20.1% |
| Total | $31.07 avg | 13,662 | $424K | 100% |
| Filing → |
| ALDR | SELL | 2016-11-09 | $252K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |
| ALDR | SELL | 2016-08-03 | $622K | — | Filing → |